Cipla’s arm enters into JVA to incorporate joint venture company in Iran

15 Dec 2016 Evaluate

Cipla’s wholly owned subsidiary in Netherlands - Cipla Holding B. V. (Cipla Netherlands), has entered into a joint venture agreement (JVA) with Ahran Tejarat Company to incorporate a joint venture company. As per the joint venture agreement, Cipla Netherlands will hold a 75% stake in a joint venture company in Iran while the JV Partner shall hold the remaining 25% stake. 

The total expected investment of Cipla Netherlands in cash in the joint venture company is estimated at being up to a maximum of 16.875 million euro. The joint venture company proposes to undertake manufacturing and marketing of pharmaceutical products in Iran.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.



Cipla Share Price

1403.00 -31.60 (-2.20%)
16-Jan-2026 11:52 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.20
Dr. Reddys Lab 1191.55
Cipla 1403.00
Zydus Lifesciences 882.15
Lupin 2210.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×